167 related articles for article (PubMed ID: 6355720)
1. THELEP controlled clinical trials in lepromatous leprosy.
Lepr Rev; 1983 Sep; 54(3):167-76. PubMed ID: 6355720
[No Abstract] [Full Text] [Related]
2. Polytherapy in multibacillary leprosy patients in Nepal.
Samuel NM; Samual S; Fairbairn T; Adiga RB
Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403
[No Abstract] [Full Text] [Related]
3. Recent trends in chemotherapy of leprosy.
Parikh DA; Maniar JK; Parikh AC; Ganapati R
J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
[No Abstract] [Full Text] [Related]
4. Multi-drug therapy of leprosy.
Ramu G
Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
[No Abstract] [Full Text] [Related]
5. Chemotherapy of leprosy for control programmes: scientific basis and practical application.
Rees RJ
Lepr Rev; 1983 Jun; 54(2):81-7. PubMed ID: 6888143
[No Abstract] [Full Text] [Related]
6. Multi-drug therapy in leprosy: an effective method of control.
Indian J Lepr; 1984; 56(1):102-12. PubMed ID: 6548238
[TBL] [Abstract][Full Text] [Related]
7. Treatment of leprosy with rifampicin and isoprodian (L73A).
Terencio de las Aguas J
Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
[No Abstract] [Full Text] [Related]
8. Rifampicin and isoprodian in combination in the treatment of leprosy.
Depasquale G
Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
[No Abstract] [Full Text] [Related]
9. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia.
Rohde R
Lepr Rev; 1975 Jun; 46(2 Suppl):199-205. PubMed ID: 1100961
[No Abstract] [Full Text] [Related]
10. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
Innami S; Leguizamón OR; Alvarenga AE
Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
[No Abstract] [Full Text] [Related]
11. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
Krenzien HN
Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
[No Abstract] [Full Text] [Related]
12. Evaluation of treatment of lepromatous leprosy patients in the Netherlands.
Faber WR; Leiker DL
Dermatologica; 1979; 158(1):46-54. PubMed ID: 367843
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
Colin M; de Montaigne E
Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy in leprosy.
Gatti JC
Lepr Rev; 1975 Jun; 46(2 Suppl):155-60. PubMed ID: 1100955
[No Abstract] [Full Text] [Related]
15. [Chemotherapy of leprosy. II. Sulfones and sulfonamides].
Leiker DL
Ned Tijdschr Geneeskd; 1980 Jan; 124(2):46-8. PubMed ID: 7374822
[No Abstract] [Full Text] [Related]
16. Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
Freerksen E
Lepr Rev; 1975 Jun; 46(2 Suppl):161-3. PubMed ID: 1165695
[No Abstract] [Full Text] [Related]
17. Combined chemotherapy of multibacillary leprosy of 6 months' duration.
Onsun N; Saylan T; Pattyn SR
Lepr Rev; 1986; 57 Suppl 3():124-6. PubMed ID: 3573952
[No Abstract] [Full Text] [Related]
18. Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):135-9. PubMed ID: 945234
[No Abstract] [Full Text] [Related]
19. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
20. Treatment of Hansen's disease.
Alto WA
Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
